HIV/AIDS

Thumbnail for Gilead’s Lenacapavir PrEP gets FDA Review

21 February 2025

Gilead’s Lenacapavir PrEP gets FDA Review

Thumbnail for Uganda seeks US$82 M to address HIV/AIDS funding shortfall

12 February 2025

Uganda seeks US$82 M to address HIV/AIDS funding shortfall

Thumbnail for US Aid suspension leaves vulnerable Ethiopians without HIV services

7 February 2025

US Aid suspension leaves vulnerable Ethiopians without HIV services

Thumbnail for Nigeria faces healthcare crisis as US suspends HIV treatment funding

29 January 2025

Nigeria faces healthcare crisis as US suspends HIV treatment funding

Thumbnail for Kenya hosts UNAIDS meeting as AHF calls for global audit of HIV data

17 December 2024

Kenya hosts UNAIDS meeting as AHF calls for global audit of HIV data

Thumbnail for Rwanda to introduce injectable HIV prevention drug

3 December 2024

Rwanda to introduce injectable HIV prevention drug

Thumbnail for MSF prepares to roll out long-acting HIV prevention injection in Africa

29 November 2024

MSF prepares to roll out long-acting HIV prevention injection in Africa

Thumbnail for Naobios collaborates with Sumagen to scale up HIV vaccine production

30 October 2024

Naobios collaborates with Sumagen to scale up HIV vaccine production

Thumbnail for EVA Pharma signs agreement with Gilead to expand access to HIV treatment

7 October 2024

EVA Pharma signs agreement with Gilead to expand access to HIV treatment

Thumbnail for Uganda expands HIV prevention options with injectable CAB-LA

28 August 2024

Uganda expands HIV prevention options with injectable CAB-LA